Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pamela Nabeta

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Journal of the Pediatric Infectious Diseases Society|October 31, 2022
Pediatric Tuberculosis Diagnostics: Present and FutureFrancesca Wanda Basile, Pamela Nabeta, Morten Ruhwald, et al.
The Indian Journal of Medical Research|June 6, 2012
Need to confirm isoniazid susceptibility in Xpert MTB/RIF rifampin susceptible casesViral Vadwai, Catharina Boehme, Pamela Nabeta, et al.
Journal of Infection in Developing Countries|December 17, 2009
Knowledge and attitudes of tuberculosis management in San Juan de Lurigancho district of Lima, PeruElizabeth M Kiefer, Theresa Shao, Olveen Carrasquillo, et al.
Microbiology Spectrum|August 18, 2021
Retrospective Diagnostic Accuracy Study of Abbott RealTi<i>m</i>e MTB against Xpert MTB/RIF Ultra and Xpert MTB/RIF for the Diagnosis of Pulmonary Tuberculosis and Susceptibility to Rifampin and Isoniazid TreatmentPatrick Howlett, Pamela Nabeta, Nestan Tukvadze, et al.
Journal of Clinical Microbiology|May 20, 2011
Xpert MTB/RIF: a new pillar in diagnosis of extrapulmonary tuberculosis?Viral Vadwai, Catharina Boehme, Pamela Nabeta, et al.
Diagnostic Microbiology and Infectious Disease|March 17, 2020
First clinical assessment of a prototype assay to detect the enzymatic activity of β-lactamase as a marker for pulmonary tuberculosisPamela Nabeta, Pratibha Seshadri, Joshua Havumaki, et al.
Plos One|September 13, 2012
A diagnostic accuracy study of Xpert®MTB/RIF in HIV-positive patients with high clinical suspicion of pulmonary tuberculosis in Lima, PeruGabriela Carriquiry, Larissa Otero, Elsa González-Lagos, et al.
Journal of Clinical Microbiology|January 20, 2017
FIND Tuberculosis Strain Bank: a Resource for Researchers and Developers Working on Tests To Detect Mycobacterium tuberculosis and Related Drug ResistanceBelay Tessema, Pamela Nabeta, Eloise Valli, et al.
Current Microbiology|October 5, 2023
GeneXpert Ultra in Urine Samples for Diagnosis of Extra-Pulmonary TuberculosisUrvashi B Singh, K P Angitha, Anuj Bhatnagar, et al.
BMC Public Health|April 10, 2022
Protocol for a cluster randomised controlled trial of secondary distribution of hepatitis C self-testing within the context of a house-to-house hepatitis C micro-elimination programme in Karachi, PakistanSonjelle Shilton, Dania Ali, Alyia Hasnain, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Journal of the Pediatric Infectious Diseases Society|October 31, 2022
Pediatric Tuberculosis Diagnostics: Present and FutureFrancesca Wanda Basile, Pamela Nabeta, Morten Ruhwald, et al.
The Indian Journal of Medical Research|June 6, 2012
Need to confirm isoniazid susceptibility in Xpert MTB/RIF rifampin susceptible casesViral Vadwai, Catharina Boehme, Pamela Nabeta, et al.
Journal of Infection in Developing Countries|December 17, 2009
Knowledge and attitudes of tuberculosis management in San Juan de Lurigancho district of Lima, PeruElizabeth M Kiefer, Theresa Shao, Olveen Carrasquillo, et al.
Microbiology Spectrum|August 18, 2021
Retrospective Diagnostic Accuracy Study of Abbott RealTi<i>m</i>e MTB against Xpert MTB/RIF Ultra and Xpert MTB/RIF for the Diagnosis of Pulmonary Tuberculosis and Susceptibility to Rifampin and Isoniazid TreatmentPatrick Howlett, Pamela Nabeta, Nestan Tukvadze, et al.
Journal of Clinical Microbiology|May 20, 2011
Xpert MTB/RIF: a new pillar in diagnosis of extrapulmonary tuberculosis?Viral Vadwai, Catharina Boehme, Pamela Nabeta, et al.
Diagnostic Microbiology and Infectious Disease|March 17, 2020
First clinical assessment of a prototype assay to detect the enzymatic activity of β-lactamase as a marker for pulmonary tuberculosisPamela Nabeta, Pratibha Seshadri, Joshua Havumaki, et al.
Plos One|September 13, 2012
A diagnostic accuracy study of Xpert®MTB/RIF in HIV-positive patients with high clinical suspicion of pulmonary tuberculosis in Lima, PeruGabriela Carriquiry, Larissa Otero, Elsa González-Lagos, et al.
Journal of Clinical Microbiology|January 20, 2017
FIND Tuberculosis Strain Bank: a Resource for Researchers and Developers Working on Tests To Detect Mycobacterium tuberculosis and Related Drug ResistanceBelay Tessema, Pamela Nabeta, Eloise Valli, et al.
Current Microbiology|October 5, 2023
GeneXpert Ultra in Urine Samples for Diagnosis of Extra-Pulmonary TuberculosisUrvashi B Singh, K P Angitha, Anuj Bhatnagar, et al.
BMC Public Health|April 10, 2022
Protocol for a cluster randomised controlled trial of secondary distribution of hepatitis C self-testing within the context of a house-to-house hepatitis C micro-elimination programme in Karachi, PakistanSonjelle Shilton, Dania Ali, Alyia Hasnain, et al.
Pageof 4